0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Prescribing Behavior
 61-80 of 136 Articles
Editorial | 
Patrick G. O’Malley, MD, MPH
Arch Intern Med. 2012;172(10):759-760. doi:10.1001/archinternmed.2012.789.

Research Letters |  FREE
Genevieve Pham-Kanter, PhD; G. Caleb Alexander, MD, MS; Kavita Nair, PhD
Arch Intern Med. 2012;172(10):819-821. doi:10.1001/archinternmed.2012.1210.

Commentary | 
Beth D. Darnall, PhD; Brett R. Stacey, MD
Arch Intern Med. 2012;172(5):431-432. doi:10.1001/archinternmed.2011.1741.

Research Letters |  FREE
Constance Guille, MD; Srijan Sen, MD, PhD
Arch Intern Med. 2012;172(4):371-372. doi:10.1001/archinternmed.2011.791.

Editor's Correspondence | 
Alain Braillon, MD, PhD
Arch Intern Med. 2012;172(3):294. doi:10.1001/archinternmed.2011.760.

Editor's Correspondence | 
Elizabeth L. Auchincloss, MD; Richard A. Friedman, MD; James H. Kocsis, MD
Arch Intern Med. 2012;172(3):294-295. doi:10.1001/archinternmed.2011.809.

Editor's Correspondence | 
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS
Arch Intern Med. 2012;172(3):294-295. doi:10.1001/archinternmed.2011.1405.

Editor's Correspondence | 
Gordon D. Schiff, MD; Bill L. Galanter, MD, PhD; Bruce L. Lambert, PhD
Arch Intern Med. 2012;172(3):294-295. doi:10.1001/archinternmed.2011.1564.

Research Letters |  FREE
Thomas J. Moore, AB; Sonal Singh, MD, MPH; Curt D. Furberg, MD, PhD
Arch Intern Med. 2012;172(1):78-80. doi:10.1001/archinternmed.2011.618.
Includes: Supplemental Content

Invited Commentary | 
Michael A. Steinman, MD
Arch Intern Med. 2011;171(16):1468-1469. doi:10.1001/archinternmed.2011.369.

Original Investigation |  FREE
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS
Arch Intern Med. 2011;171(16):1463-1468. doi:10.1001/archinternmed.2011.396.
Includes: Supplemental Content

Review Article |  FREE
Gordon D. Schiff, MD; William L. Galanter, MD, PhD; Jay Duhig, MA; et al.
Arch Intern Med. 2011;171(16):1433-1440. doi:10.1001/archinternmed.2011.256.

Review Article |  FREE
Daniel G. Hackam, MD, PhD; Kaveh G. Shojania, MD; J. David Spence, MD; et al.
Arch Intern Med. 2011;171(11):977-982. doi:10.1001/archinternmed.2011.69.

Invited Commentary | 
Amanda H. Salanitro, MD, MSPH; Sunil Kripalani, MD, MSc
Arch Intern Med. 2011;171(9):822-823. doi:10.1001/archinternmed.2010.481.

Original Investigation |  FREE
Michael S. Wolf, PhD, MPH; Laura M. Curtis, MS; Katherine Waite, BA; et al.
Arch Intern Med. 2011;171(4):300-305. doi:10.1001/archinternmed.2011.39.

Articles | 
Arch Intern Med. 2010;170(22):1966. doi:10.1001/archinternmed.2010.452.

Original Investigation |  FREE
Eric G. Campbell, PhD; Sowmya R. Rao, PhD; Catherine M. DesRoches, DrPh; et al.
Arch Intern Med. 2010;170(20):1820-1826. doi:10.1001/archinternmed.2010.383.

Original Investigation |  FREE
Hugo M. Smeets, PhD; Niek J. de Wit, MD, PhD; Nicolaas P. A. Zuithoff, MSc; et al.
Arch Intern Med. 2010;170(14):1264-1268. doi:10.1001/archinternmed.2010.224.

Editor's Correspondence | 
Glen L. Xiong, MD; Y. Pritham Raj, MD
Arch Intern Med. 2010;170(10):917-918. doi:10.1001/archinternmed.2010.143.

Editor's Correspondence | 
Yong Chen, MD, MHS; Becky A. Briesacher, PhD; Terry S. Field, DSc; et al.
Arch Intern Med. 2010;170(10):917-918. doi:10.1001/archinternmed.2010.144.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
From the JAMA Network  | 
Treating Prescription Opioid Dependence
Charles Ruetsch, PhD
JAMA
Medical News & Perspectives  | 
Reports: HIV Drugs Targeted for Black Market
Bridget M. Kuehn, MSJ
JAMA
Medical News & Perspectives  | 
CDC: Major Disparities in Opioid Prescribing Among States:  Some States Crack Down on Excess Prescribing
Bridget M. Kuehn, MSJ
JAMA Neurology
Editorial  | 
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Olaf Stüve, MD, PhD; Gary R. Cutter, PhD